What should you know about neuroendocrine lung cancer?

Neuroendocrine cells can release signalling substances, and lung tumours with these features include different diseases such as small-cell lung cancer and some well-differentiated neuroendocrine tumours. A pathologist examines tissue to identify the subtype, while scans show the tumour's location and whether it has spread.

Cough, breathlessness, chest discomfort, fatigue, or a hoarse voice may occur, but none of these symptoms identifies neuroendocrine lung cancer by itself. If cancer spreads to the brain, symptoms can include headaches, seizures, confusion, or new weakness, which require prompt assessment.

Ask which subtype and stage the biopsy supports and whether genomic tumour profiling is useful. Depending on the findings, care may include chemotherapy, radiotherapy, lung lobectomy, or symptom-focused palliative care. The team may combine treatments to control the tumour, ease breathing or pain, and support daily function.

Get emergency help for severe breathlessness, blue lips, coughing up more than a small amount of blood, a seizure, sudden confusion, new one-sided weakness, or rapidly worsening chest pain. Contact the oncology team promptly for new hoarseness, worsening cough, or difficulty swallowing.

Which neuroendocrine subtype is present? What do the scans show about the lungs, lymph nodes, and brain? Would genomic tumour profiling change the plan? What is the purpose of each treatment? How will breathing, nutrition, pain, and treatment effects be supported?